Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr;14(4):219-32.
doi: 10.1038/nrc3702.

Targeting Bruton's tyrosine kinase in B cell malignancies

Rudi W Hendriks  1 , Saravanan Yuvaraj  1 , Laurens P Kil  1
Affiliations
Review

Targeting Bruton's tyrosine kinase in B cell malignancies

Rudi W Hendriks et al. Nat Rev Cancer. 2014 Apr.

Abstract

Bruton's tyrosine kinase (BTK) is a key component of B cell receptor (BCR) signalling and functions as an important regulator of cell proliferation and cell survival in various B cell malignancies. Small-molecule inhibitors of BTK have shown antitumour activity in animal models and, recently, in clinical studies. High response rates were reported in patients with chronic lymphocytic leukaemia and mantle cell lymphoma. Remarkably, BTK inhibitors have molecular effects that cannot be explained by the classic role of BTK in BCR signalling. In this Review, we highlight the importance of BTK in various signalling pathways in the context of its therapeutic inhibition.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Blood. 2011 Jun 9;117(23):6287-96 - PubMed
    1. Blood. 2011 Feb 3;117(5):1662-9 - PubMed
    1. J Biol Chem. 1999 Jul 9;274(28):19752-61 - PubMed
    1. Leuk Lymphoma. 2003 Jun;44(6):1011-8 - PubMed
    1. J Exp Med. 2004 Oct 4;200(7):927-34 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources